⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

SLB's 2025 10-K removed the COVID-19 pandemic risk disclosure, reflecting a shift away from acute public health emergency concerns that dominated 2024 disclosures. The filing introduced two new risks specific to the proposed ChampionX acquisition, addressing both completion risk and post-acquisition integration risk, indicating that deal-related uncertainties have become material risk factors requiring disclosure.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟢 New in Current Filing We may be unable to complete the proposed acquisition of ChampionX. 🔒

🟢 New in Current Filing We may fail to realize the anticipated benefits of the proposed acquisition of ChampionX. 🔒

🔴 No Match in Current Filing Public health emergencies, such as the COVID-19 pandemic, and resulting adverse economic conditions have had, and may continue to have, a material adverse effect on our financial condition, results of operations, and cash flows. 🔒

3 changes in this historical filing

Historical year-over-year comparisons (2025 vs 2024 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →